Pancreatic cancer stem cells (PCSCs) promote tumor growth and progression through several mechanisms, including tumor-initiation by inducing stem cell markers CD44, CD24, and CD133, and evasion of conventional therapies (Zhou et al., 2017). Here, PROM1 is linked to neoplasm.